CompoAtlas

Nature Phyto Super Shirafza

Natural health product licensed in Canada

Other names
Super Shirafza
Licence holder
Bestin Pharma Inc.
NPN or DIN-HM
80060991
Status
Inactive licence
Licence date
19 May 2015
Revision date
Not provided
Form
Capsule
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Carum carvi

Source : Graine(s)

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 500 milligramme

100 milligramme
Trigonella foenum-graecum

Source : Semence(s)

Extract : Matériel brut sec

Extraction ratio : 20:1

Dry plant equivalent : 3,000 milligramme

150 milligramme
Pimpinella anisum

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 1,000 milligramme

100 milligramme

Non-medicinal ingredients

Gélatine, Stéarate de magnésium, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule3 days

Uses authorised in Canada

Text supplied in English because no French text is available.

Used in Herbal Medicine as galactogogue/lactogogue to help promote milk production/secretion. Caraway is traditionally used in Herbal Medicine to aid digestion and to help stimulate appettite (stomachic). Caraway is traditionally used in Herbal Medicine to help relieve digestive spasms (anti-spasmodic) and flatulent dyspepsia (carminative).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80060991

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line